Summary

Contact us
On January 17, 2024, Belgium inaugurated its new Health Data Agency, a project approved a year earlier. The agency is designed to improve the accessibility and reusability of health data for secondary purposes. This enhancement of data availability will be executed in a manner that ensures both security and adherence to privacy regulations.

Data types Involved

The data encompasses a broad spectrum. Founding members of the ADS (Sciensano, INAMI, SPF Public Health, KCE, AFPMS) have established a framework to map out the extensive data sets targeted, which include health, diseases, medical equipment and products, health determinants, related activities, etc. According to an agency program manager, this data will inherently be public and anonymized.

Structure of the Repository

The platform, as it currently stands, is relatively straightforward. It lists a variety of accessible datasets, while the agency itself does not hold the data. The data is organized using the DCAT_AP format.

Role of the Health Data Agency

The agency acts as an intermediary, facilitating the interaction between those who reuse data and the entities that own it. It offers tools and legal advice to aid in data exchange. Moreover, the agency is responsible for verifying the identity and intentions of data reusers, aligning its operations with the guidelines set forth by the European Health Data Space.

Contact us

FAQs

Our frequently questions

No items found.

Seamus Larroque

CDPO / CPIM / ISO 27005 Certified

Find out how iliomad can help your company.

[Map placeholder]
Only visible in production
38.709099
-39.182035
1.6
6d17042a3425c5b3
Your message has been received!
We'll get back to you as soon as possible.
Something went wrong, please try again.
Home

Discover our latest articles

View All Blog Posts
Abstract digital network connecting a hospital, a regulatory building and a courtroom, representing AI governance, health data privacy and transatlantic data transfer risks in 2026
July 8, 2026
Healthtech
Regulations & Guidelines
DPIA
Regulation
LLMS

AI Triage, Biopharma Workbenches and Crumbling Data Bridges: iliomad Weekly Digest

NHS AI triage, Anthropic Claude Science, medical AI privacy risks, MHRA GxP guidance, EDPS ADM checklist and the EU-US data transfer threat explained.

A clinical data reviewer examining an automated decision output on a screen, representing human oversight in GDPR clinical trials under the EDPS ADM checklist framework
July 6, 2026
GDPR
Regulation
Clinical Trials
US Privacy Law
EU Privacy Law

Human Intervention in Automated Decision-Making: What the EDPS Checklist Means for Life Sciences

The EDPS checklist on human intervention in automated decision-making carries direct implications for GDPR clinical trials. Learn what effective oversight requires.

A clinical trial investigator reviewing an informed consent form with a data protection checklist highlighting the ethnicity data justification section
July 3, 2026
ICF
GDPR
Clinical Trials
Ethics Committee
Combination Products

Informed Consent Form (ICF) and Ethnicity Data: Justification Requirements Under GDPR and MR-001

Ethics committees require scientific justification for ethnicity data in the ICF. Learn how GDPR Article 9, MR-001 and EU CTR 536/2014 apply to your clinical trial.